BioTek awarded patent for Hybrid Technology in multimode microplate readers
BioTek has been awarded US patent 8,218,141 covering the combination of two alternate paths for light within the same analytical instrument. Known as Hybrid Technology, the patented functionality is available in BioTek’s Synergy NEO HTS Multi-Mode Microplate Reader and in the Synergy H4 and H1 Hybrid Multi-Mode Microplate Readers.
Using Hybrid Technology, light can be directed to and from the microplate samples through a filter-based optical system or through a monochromator-based optical system for wavelength selection. This two-optical-path system provides optimal performance and flexibility for a wide range of applications in fluorescence microplate assays. The company’s Synergy readers are modular platforms that can include fluorescence intensity, UV-Vis absorbance, luminescence, TRF, TR-FRET and FP detection modes.
BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process, provide rapid and cost-effective industrial analysis and to enable sensitive and accurate quantification of a wide range of molecules across diverse applications.
Light-powered DNA detection removes the need for PCR
Unlike PCR, which amplifies DNA sequences by making millions of copies of target DNA for...
Early Parkinson's detection with an RNA-based blood test
The test has the potential to alleviate the uncertainty faced by patients and clinicians,...
Biomarkers for SIDS found in blood samples
US researchers have revealed the fingerprints of sudden infant death syndrome (SIDS) within blood...
